- Benign tumor
- Breast cancer
- Breast sarcoma
- Gynecologic cancer
- Gynecological sarcomas
- Brachytherapy
- Proton therapy
- Radiation therapy
Neil K. Taunk, MD, MSCTS
Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Rena Rowan Breast Center
Penn Medicine Provider
About me
- Chief, Breast Radiation Service
- Chief, Gynecologic Radiation Service
- Director, Imaging Sciences in Radiation Oncology
- Director, Brachytherapy and Procedural Radiation
- Associate Professor of Radiation Oncology at the Hospital of the University of Pennsylvania
- Assistant Professor of Radiation Oncology in Radiology
My education and training
- Medical School: University of Medicine and Dentistry of New Jersey
- Residency: Mount Sinai Hospital
- Residency: Memorial Sloan-Kettering Cancer Center
Spoken languages
English
English
हिन्दी
Hindi
Reviews
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Taunk is a Penn Medicine physician.
Qualifications and experience
- Radiation Oncology, 2018
- American Board of Radiology, National
- American Brachytherapy Society (ABS), National
- American Cancer Society, National
- American Society for Radiation Oncology (ASTRO), National
- Commission on Accreditation of Medical Physics Education Programs (CAMPEP), International
- ECOG-ACRIN, National
- Living Beyond Breast Cancer, National
- NRG Oncology, National
- Radiologic Society of North America (RSNA), National
- Society of Nuclear Medicine and Molecular Imaging (SNMNI), National
- Penn Breast Cancer Program
- Penn Genitourinary and Urologic Cancer Program
- Penn Gynecologic Oncology Program
- Penn Neuroendocrine Tumor Program
Treatments and conditions
Research
Publications
Smith EE, Heintz JR, Chesnokova A, Taunk NK. Improving Treatment of Radiation-Induced Premature Ovarian Insufficiency After Cervical Cancer: A Practice Quality Improvement Initiative , Int J Radiat Oncol Biol Phys, 126: 2026,48-54
Wright JL, Ko K, Kenworthy W, Bosch W, Straube W, Zou W, Remmes N, Pankuch M, Berlin E, Berrington de Gonzalez A, Boggs DH, Braunstein LZ, Cahlon O, Chawla A, Croog V, Fagundes M, Fang LC, Feriozzi A, Freedman GM, Gillespie EF, Hoffman K, Jimenez RB, Kim J, Lu HL, MacDonald S, Meier T, Mishra M, Mutter R, Ohri N, Pugh SL, Rosen L, Taghian A, Taunk N, Thukral AD, Urbanic J, Bekelman JE, Lin A, Ky B; RadComp Consortium. Associations Between Cardiac Radiation Dose-Volume Metrics and Health-Related Quality of Life for Patients With Breast Cancer on the RadComp Trial , Int J Radiat Oncol Biol Phys: 2026
Mulugeta PG, O'Brien SR, Mankoff DA, Sartor O, Taunk NK. A Call for High-Level Evidence Before Routine Implementation of Posttreatment SPECT , J Nucl Med, 67: 2026,1172-1173
Atobiloye M, Howell J, Cruttenden J, Weil C, Taunk N, Suneja G, Gaffney D, Burt L, DeCesaris C. Improved Overall Survival Associated With Vaginal Cuff Brachytherapy Boost for Stage II Endometrioid Endometrial Cancer , Adv Radiat Oncol, 11: 2026,102124
Pepin A, Doucette A, Narayan VK, Maxwell KN, Takvorian SU, O'Brien SR, Mankoff DA, Mulugeta PG, Taunk NK. Differential Response to (177)Lu-PSMA-617 in Patients with Tumor Suppressor Gene-Mutated Metastatic Castration-Resistant Prostate Cancer , J Nucl Med, 67: 2026,926-928
Khan S, Olsen TC, Voytik M, Sun F, Riina MD, Broach RB, Hsu JY, Freedman GM, Taunk NK, Azoury SC. The Relationship of Radiation Therapy Parameters and Perioperative Morbidity and Toxicities on Breast Reconstruction Outcomes , Ann Plast Surg, 96: 2026,S319-S325
Howell JN, Wilkes J, Maughan NM, Patel RB, Barney B, Taunk NK, Escorcia FE, Johnson SB, Boothe D. Industry Sponsorship and Disease Site Focus in Therapeutic Radiopharmaceutical Clinical Trials Over the Past Decade , Int J Radiat Oncol Biol Phys, 124: 2026,575-580
Go AE, Feliciano EJG, Martinez J, Ho FDV, Wu JF, Willmann J, Lapen K, Hugo H, Jeong Y, Singh A, Haylock AB, Shah N, Robredo JPG, Eala MAB, Patel RK, Chen J, Cabaero MLL, Tawfiles D, Venkateswaran S, Tan AKNG, Gyawali B, Moraes FY, Iyengar P, Lee NY, Mango VL, Taunk NK, Magsanoc-Alikpala MJK, Kingham TP, Dee EC. Global determinants of cervical cancer outcomes: a health systems analysis , BMJ Oncol, 5: 2026,e000975
Pepin A, Almeida ND, Fung-Kee-Fung S, Kassick M, Taunk NK, Freedman GM. Boost Approaches in Patients Undergoing Postoperative Radiotherapy , J Surg Oncol: 2026
O'Brien SR, Pantel AR, Taunk N, Mankoff D, Gray D, Mulugeta P. Creating a dedicated radionuclide therapy clinic and leveraging telemedicine to increase access to radiopharmaceutical therapies , Clin Imaging: 2026